What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Immune system
His primary scientific interests are in Internal medicine, Immunology, Transplantation, Progenitor cell and Pathology.
Within one scientific family, he focuses on topics pertaining to Cardiology under Internal medicine, and may sometimes address concerns connected to Homeobox protein NANOG.
His Immunology research integrates issues from TOR Serine-Threonine Kinases, Hematopoietic stem cell transplantation, Stem cell and Genetic transfer.
The study incorporates disciplines such as Leukemia and Mesenchymal stem cell in addition to Stem cell.
His Transplantation research is within the category of Surgery.
His study looks at the relationship between Pathology and fields such as Cardiac function curve, as well as how they intersect with chemical problems.
His most cited work include:
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (959 citations)
- The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation (791 citations)
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial (374 citations)
What are the main themes of his work throughout his whole career to date?
Jérôme Larghero mostly deals with Immunology, Transplantation, Stem cell, Internal medicine and Cell biology.
The Transplantation study combines topics in areas such as Survival rate and Cord blood.
He has researched Stem cell in several fields, including Induced pluripotent stem cell and Pathology.
His studies deal with areas such as Gastroenterology, Oncology and Cardiology as well as Internal medicine.
His Cell biology research is multidisciplinary, relying on both Angiogenesis and Cell type.
His Bone marrow study combines topics from a wide range of disciplines, such as CD34, Cancer research and Mesenchymal stem cell.
He most often published in these fields:
- Immunology (35.29%)
- Transplantation (30.51%)
- Stem cell (34.93%)
What were the highlights of his more recent work (between 2016-2021)?
- Cell biology (22.43%)
- Mesenchymal stem cell (22.43%)
- Stem cell (34.93%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cell biology, Mesenchymal stem cell, Stem cell, Internal medicine and Transplantation.
His work on Progenitor cell as part of general Cell biology research is often related to Heme, thus linking different fields of science.
His study in Progenitor cell is interdisciplinary in nature, drawing from both Hindlimb, Chemokine, Immunology and Ischemia.
Jérôme Larghero studies Stem cell, namely Haematopoiesis.
Many of his studies on Internal medicine apply to Oncology as well.
His Transplantation study integrates concerns from other disciplines, such as Clinical endpoint and Heart failure, Cardiology.
Between 2016 and 2021, his most popular works were:
- Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction (153 citations)
- Convergence of microengineering and cellular self-organization towards functional tissue manufacturing (45 citations)
- Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (43 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Immune system
Cell biology, Progenitor cell, Cancer research, Transplantation and Immunology are his primary areas of study.
His Progenitor cell study combines topics in areas such as Haematopoiesis and Marginal zone.
His Haematopoiesis study is associated with Stem cell.
His research in Cancer research intersects with topics in Adipose tissue, T cell and Bone marrow.
His study on Transplantation is covered under Internal medicine.
His work on B cell as part of general Immunology research is frequently linked to Interleukin-7 receptor, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
